vs
Astrana Health, Inc.（ASTH）与Montrose Environmental Group, Inc.（MEG）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Montrose Environmental Group, Inc.的4.9倍（$950.5M vs $193.3M）。Astrana Health, Inc.净利率更高（0.7% vs -4.3%，领先4.9%）。Astrana Health, Inc.同比增速更快（42.9% vs 2.2%）。Montrose Environmental Group, Inc.自由现金流更多（$46.5M vs $-6.0M）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 11.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
蒙特罗斯环境集团是一家美国跨国企业，主营各类环境服务，业务覆盖环境行业全产业链，可为公共部门及私营领域客户提供一体化支持。公司总部位于阿肯色州小石城，在美国特拉华州完成注册。
ASTH vs MEG — 直观对比
营收规模更大
ASTH
是对方的4.9倍
$193.3M
营收增速更快
ASTH
高出40.7%
2.2%
净利率更高
ASTH
高出4.9%
-4.3%
自由现金流更多
MEG
多$52.5M
$-6.0M
两年增速更快
ASTH
近两年复合增速
11.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $193.3M |
| 净利润 | $6.6M | $-8.2M |
| 毛利率 | — | 38.6% |
| 营业利润率 | 1.9% | -1.3% |
| 净利率 | 0.7% | -4.3% |
| 营收同比 | 42.9% | 2.2% |
| 净利润同比 | 184.4% | 70.9% |
| 每股收益（稀释后） | $0.12 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHMEG
| Q4 25 | $950.5M | $193.3M | ||
| Q3 25 | $956.0M | $224.9M | ||
| Q2 25 | $654.8M | $234.5M | ||
| Q1 25 | $620.4M | $177.8M | ||
| Q4 24 | $665.2M | $189.1M | ||
| Q3 24 | $478.7M | $178.7M | ||
| Q2 24 | $486.3M | $173.3M | ||
| Q1 24 | $404.4M | $155.3M |
净利润ASTHMEG
| Q4 25 | $6.6M | $-8.2M | ||
| Q3 25 | $373.0K | $8.4M | ||
| Q2 25 | $9.4M | $18.4M | ||
| Q1 25 | $6.7M | $-19.4M | ||
| Q4 24 | $-7.8M | $-28.2M | ||
| Q3 24 | $16.1M | $-10.6M | ||
| Q2 24 | $19.2M | $-10.2M | ||
| Q1 24 | $14.8M | $-13.4M |
毛利率ASTHMEG
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 40.8% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 39.9% | ||
| Q1 24 | — | 37.8% |
营业利润率ASTHMEG
| Q4 25 | 1.9% | -1.3% | ||
| Q3 25 | 2.0% | 4.4% | ||
| Q2 25 | 3.1% | 6.4% | ||
| Q1 25 | 3.3% | -5.9% | ||
| Q4 24 | 0.1% | -12.1% | ||
| Q3 24 | 5.9% | -0.6% | ||
| Q2 24 | 6.2% | -1.5% | ||
| Q1 24 | 7.5% | -6.5% |
净利率ASTHMEG
| Q4 25 | 0.7% | -4.3% | ||
| Q3 25 | 0.0% | 3.7% | ||
| Q2 25 | 1.4% | 7.8% | ||
| Q1 25 | 1.1% | -10.9% | ||
| Q4 24 | -1.2% | -14.9% | ||
| Q3 24 | 3.4% | -5.9% | ||
| Q2 24 | 3.9% | -5.9% | ||
| Q1 24 | 3.7% | -8.6% |
每股收益（稀释后）ASTHMEG
| Q4 25 | $0.12 | $-0.13 | ||
| Q3 25 | $0.01 | $0.21 | ||
| Q2 25 | $0.19 | $0.42 | ||
| Q1 25 | $0.14 | $-0.64 | ||
| Q4 24 | $-0.14 | $-0.91 | ||
| Q3 24 | $0.33 | $-0.39 | ||
| Q2 24 | $0.40 | $-0.39 | ||
| Q1 24 | $0.31 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $11.2M |
| 总债务越低越好 | — | $277.1M |
| 股东权益账面价值 | $779.3M | $451.2M |
| 总资产 | $2.2B | $981.3M |
| 负债/权益比越低杠杆越低 | — | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资ASTHMEG
| Q4 25 | $429.5M | $11.2M | ||
| Q3 25 | $463.4M | $6.7M | ||
| Q2 25 | $342.1M | $10.5M | ||
| Q1 25 | $260.9M | $30.3M | ||
| Q4 24 | $290.8M | $12.9M | ||
| Q3 24 | $350.3M | $13.0M | ||
| Q2 24 | $327.7M | $16.9M | ||
| Q1 24 | $337.3M | $9.5M |
总债务ASTHMEG
| Q4 25 | — | $277.1M | ||
| Q3 25 | — | $302.4M | ||
| Q2 25 | — | $264.6M | ||
| Q1 25 | — | $235.6M | ||
| Q4 24 | — | $204.8M | ||
| Q3 24 | — | $233.0M | ||
| Q2 24 | — | $188.7M | ||
| Q1 24 | — | $280.9M |
股东权益ASTHMEG
| Q4 25 | $779.3M | $451.2M | ||
| Q3 25 | $775.5M | $458.7M | ||
| Q2 25 | $765.5M | $470.3M | ||
| Q1 25 | $745.4M | $444.1M | ||
| Q4 24 | $712.7M | $446.3M | ||
| Q3 24 | $704.6M | $449.2M | ||
| Q2 24 | $678.9M | $448.8M | ||
| Q1 24 | $653.5M | $324.5M |
总资产ASTHMEG
| Q4 25 | $2.2B | $981.3M | ||
| Q3 25 | $2.2B | $985.7M | ||
| Q2 25 | $1.4B | $998.1M | ||
| Q1 25 | $1.3B | $992.2M | ||
| Q4 24 | $1.4B | $990.4M | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.3B | $943.9M | ||
| Q1 24 | $1.2B | $918.1M |
负债/权益比ASTHMEG
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.56× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.42× | ||
| Q1 24 | — | 0.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $51.9M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $46.5M |
| 自由现金流率自由现金流/营收 | -0.6% | 24.1% |
| 资本支出强度资本支出/营收 | 0.3% | 2.8% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $91.2M |
8季度趋势，按日历期对齐
经营现金流ASTHMEG
| Q4 25 | $-2.9M | $51.9M | ||
| Q3 25 | $10.0M | $28.1M | ||
| Q2 25 | $90.9M | $21.9M | ||
| Q1 25 | $16.6M | $5.5M | ||
| Q4 24 | $-10.9M | $32.0M | ||
| Q3 24 | $34.0M | $11.4M | ||
| Q2 24 | $23.2M | $894.0K | ||
| Q1 24 | $6.0M | $-22.0M |
自由现金流ASTHMEG
| Q4 25 | $-6.0M | $46.5M | ||
| Q3 25 | $7.4M | $22.3M | ||
| Q2 25 | $89.5M | $19.9M | ||
| Q1 25 | $13.6M | $2.4M | ||
| Q4 24 | $-13.5M | $29.7M | ||
| Q3 24 | $31.7M | $10.2M | ||
| Q2 24 | $20.4M | $-9.8M | ||
| Q1 24 | $5.6M | $-29.3M |
自由现金流率ASTHMEG
| Q4 25 | -0.6% | 24.1% | ||
| Q3 25 | 0.8% | 9.9% | ||
| Q2 25 | 13.7% | 8.5% | ||
| Q1 25 | 2.2% | 1.3% | ||
| Q4 24 | -2.0% | 15.7% | ||
| Q3 24 | 6.6% | 5.7% | ||
| Q2 24 | 4.2% | -5.6% | ||
| Q1 24 | 1.4% | -18.9% |
资本支出强度ASTHMEG
| Q4 25 | 0.3% | 2.8% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.2% | 0.8% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 1.2% | ||
| Q3 24 | 0.5% | 0.6% | ||
| Q2 24 | 0.6% | 6.1% | ||
| Q1 24 | 0.1% | 4.7% |
现金转化率ASTHMEG
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 3.36× | ||
| Q2 25 | 9.65× | 1.19× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MEG
暂无分部数据
